SG11201407566VA - Novel 1,3-benzoxazol-2(3h)-ones and their use as medicaments and cosmetics - Google Patents
Novel 1,3-benzoxazol-2(3h)-ones and their use as medicaments and cosmeticsInfo
- Publication number
- SG11201407566VA SG11201407566VA SG11201407566VA SG11201407566VA SG11201407566VA SG 11201407566V A SG11201407566V A SG 11201407566VA SG 11201407566V A SG11201407566V A SG 11201407566VA SG 11201407566V A SG11201407566V A SG 11201407566VA SG 11201407566V A SG11201407566V A SG 11201407566VA
- Authority
- SG
- Singapore
- Prior art keywords
- international
- novel
- bielefeld
- pct
- benzoxazol
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/007—Preparations for dry skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
- A61Q7/02—Preparations for inhibiting or slowing hair growth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/10—General cosmetic use
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/423—Oxazoles condensed with carbocyclic rings
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Toxicology (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261649587P | 2012-05-21 | 2012-05-21 | |
| EP12168639 | 2012-05-21 | ||
| PCT/EP2013/001501 WO2013174508A1 (en) | 2012-05-21 | 2013-05-21 | Novel 1,3-benzoxazol-2(3h)-ones and their use as medicaments and cosmetics |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201407566VA true SG11201407566VA (en) | 2014-12-30 |
Family
ID=49623174
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201407566VA SG11201407566VA (en) | 2012-05-21 | 2013-05-21 | Novel 1,3-benzoxazol-2(3h)-ones and their use as medicaments and cosmetics |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US9199948B2 (ja) |
| EP (1) | EP2852581B1 (ja) |
| JP (1) | JP6125619B2 (ja) |
| KR (1) | KR102054662B1 (ja) |
| AU (1) | AU2013265720B2 (ja) |
| BR (1) | BR112014029057B1 (ja) |
| CA (1) | CA2871255C (ja) |
| DK (1) | DK2852581T3 (ja) |
| ES (1) | ES2585264T3 (ja) |
| HK (1) | HK1208863A1 (ja) |
| HU (1) | HUE029645T2 (ja) |
| MX (1) | MX343073B (ja) |
| NZ (1) | NZ701291A (ja) |
| PL (1) | PL2852581T3 (ja) |
| RU (1) | RU2629936C2 (ja) |
| SG (1) | SG11201407566VA (ja) |
| WO (1) | WO2013174508A1 (ja) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3932395A1 (en) | 2020-07-03 | 2022-01-05 | Dr. August Wolff GmbH & Co. KG Arzneimittel | Stable emulsion containing an active pharmaceutical ingredient based on n(3-methyl-2-oxo-2,3-dihydrobenzo[d]oxazol-5-yl)dodecanamide, production and use |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK288287A (da) * | 1986-06-09 | 1987-12-10 | Pfizer | Heterocycliske forbindelser samt farmaceutiske praeparater til behandling af allergiske eller inflammatoriske tilstande |
| FR2674524B1 (fr) * | 1991-03-25 | 1993-05-21 | Adir | Nouveaux amides alkyl heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
| FR2717078B1 (fr) * | 1994-03-08 | 1996-12-13 | Oreal | Utilisation des acides sulfoniques comme agents antivieillissement dans une composition cosmétique ou dermatologique. |
| DE10210779A1 (de) * | 2002-03-12 | 2003-10-09 | Merck Patent Gmbh | Cyclische Amide |
| ES2557314T3 (es) | 2009-05-29 | 2016-01-25 | Dr. August Wolff Gmbh & Co. Kg Arzneimittel | Dodeca-2E,4E-dieno amidas y sus usos como medicamentos y cosméticos |
-
2013
- 2013-05-21 NZ NZ701291A patent/NZ701291A/en not_active IP Right Cessation
- 2013-05-21 AU AU2013265720A patent/AU2013265720B2/en not_active Ceased
- 2013-05-21 EP EP13723678.2A patent/EP2852581B1/en not_active Not-in-force
- 2013-05-21 JP JP2015513042A patent/JP6125619B2/ja active Active
- 2013-05-21 US US14/401,989 patent/US9199948B2/en not_active Expired - Fee Related
- 2013-05-21 WO PCT/EP2013/001501 patent/WO2013174508A1/en active Application Filing
- 2013-05-21 MX MX2014014093A patent/MX343073B/es active IP Right Grant
- 2013-05-21 PL PL13723678.2T patent/PL2852581T3/pl unknown
- 2013-05-21 RU RU2014151785A patent/RU2629936C2/ru active
- 2013-05-21 ES ES13723678.2T patent/ES2585264T3/es active Active
- 2013-05-21 HU HUE13723678A patent/HUE029645T2/en unknown
- 2013-05-21 SG SG11201407566VA patent/SG11201407566VA/en unknown
- 2013-05-21 DK DK13723678.2T patent/DK2852581T3/en active
- 2013-05-21 CA CA2871255A patent/CA2871255C/en not_active Expired - Fee Related
- 2013-05-21 KR KR1020147034448A patent/KR102054662B1/ko active IP Right Grant
- 2013-05-21 BR BR112014029057-1A patent/BR112014029057B1/pt not_active IP Right Cessation
-
2015
- 2015-09-25 HK HK15109508.9A patent/HK1208863A1/zh not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ES2585264T3 (es) | 2016-10-04 |
| CA2871255C (en) | 2017-02-28 |
| NZ701291A (en) | 2015-12-24 |
| MX2014014093A (es) | 2015-01-26 |
| EP2852581B1 (en) | 2016-05-04 |
| RU2629936C2 (ru) | 2017-09-05 |
| BR112014029057A2 (pt) | 2018-04-24 |
| HK1208863A1 (zh) | 2016-03-18 |
| AU2013265720B2 (en) | 2017-04-20 |
| US20150111935A1 (en) | 2015-04-23 |
| KR20150013728A (ko) | 2015-02-05 |
| WO2013174508A1 (en) | 2013-11-28 |
| CA2871255A1 (en) | 2013-11-28 |
| DK2852581T3 (en) | 2016-08-01 |
| CN104520279A (zh) | 2015-04-15 |
| KR102054662B1 (ko) | 2019-12-11 |
| BR112014029057B1 (pt) | 2020-12-01 |
| HUE029645T2 (en) | 2017-03-28 |
| RU2014151785A (ru) | 2016-07-20 |
| JP6125619B2 (ja) | 2017-05-10 |
| MX343073B (es) | 2016-10-21 |
| US9199948B2 (en) | 2015-12-01 |
| AU2013265720A1 (en) | 2014-11-13 |
| PL2852581T3 (pl) | 2016-11-30 |
| EP2852581A1 (en) | 2015-04-01 |
| JP2015517538A (ja) | 2015-06-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201407200TA (en) | Liquid formulation | |
| SG11201805570WA (en) | Systems and methods for long term transdermal administration | |
| SG11201906436VA (en) | Novel heterocyclic compound, its preparation method, and pharmaceutical composition comprising the same | |
| SG11201408261UA (en) | Syringe | |
| SG11201407919WA (en) | Carboxamide or sulfonamide substituted thiazoles and related derivatives as modulators for the orphan nuclear receptor ror[gamma] | |
| SG11201407971QA (en) | Paliperidone implant formulation | |
| SG11201408123SA (en) | Aminotriazolopyridine for use in the treatment of inflammation, and pharmaceutical compositions thereof | |
| SG11201407961WA (en) | Risperidone or paliperidone implant formulation | |
| SG11201408251SA (en) | A pharmaceutical composition containing nicotinic acid and/or nicotinamide and/or tryptophan for positively influencing the intestinal microbiota | |
| SG11201407397WA (en) | Formulations and methods for vaginal delivery of antiprogestins | |
| SG11201408318RA (en) | Compositions and methods for transmucosal absorption | |
| SG11201906222WA (en) | Jak1 selective inhibitors | |
| SG11201807185UA (en) | Modified hyaluronic acid, method for making same and uses thereof | |
| SG11201408641UA (en) | Phenoxyethyl piperidine compounds | |
| SG11201406987UA (en) | Glucokinase activator compositions for the treatment of diabetes | |
| SG11201407575PA (en) | 5-amino[1,4]thiazines as bace 1 inhibitors | |
| SG11201908660RA (en) | N-substituted indole derivatives | |
| SG11201809799WA (en) | Tetrahydropyrimidodiazepine and tetrahydropyridodiazepine compounds for treating pain and pain related conditions | |
| SG11201408509PA (en) | Racecadotril lipid compositions | |
| SG11201407536UA (en) | Topical pharmaceutical compositions comprising terbinafine and urea | |
| SG11201811580SA (en) | Compositions, devices, and methods for the treatment of alcohol use disorder | |
| SG11201810974QA (en) | Methods and compositions for prostate cancer diagnosis and treatment | |
| SG11201407345QA (en) | Pyrazole compounds as sglt1 inhibitors | |
| SG11201805142RA (en) | Pharmaceutical compositions comprising phenylaminopyrimidine derivative | |
| SG11201809989XA (en) | Seco macrolide compounds |